Loading company…
Won 2 federal SBIR/STTR research awards from NSF and other federal agencies.
OCULOGENEX has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $1,256,000 between 2021 and 2022. These are non-dilutive federal research grants, not equity financing. The company is based in Dallas, Texas.
No investors recorded yet for OCULOGENEX.
Add an investorOCULOGENEX has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for OCULOGENEX.
Add diversity data